Zobrazeno 1 - 6
of 6
pro vyhledávání: ''
Autor:
Godehard Scholz, Jennifer Amsler, Odile Stalder, Lisa Christ, Christoph Tappeiner, Iveta Kysela, Luca Seitz, Peter M. Villiger, Stephan Reichenbach, Florian Kollert
Publikováno v:
Arthritis Research & Therapy, Vol 23, Iss 1, Pp 1-8 (2021)
Amsler, Jennifer; Kysela, Iveta; Tappeiner, Christoph; Seitz, Luca; Christ, Lisa; Scholz, Godehard; Stalder, Odile; Kollert, Florian; Reichenbach, Stephan; Villiger, Peter (2021). Vision loss in patients with giant cell arteritis treated with tocilizumab. Arthritis research & therapy, 23(1), p. 92. BioMed Central 10.1186/s13075-021-02480-4
Arthritis Research & Therapy
Amsler, Jennifer; Kysela, Iveta; Tappeiner, Christoph; Seitz, Luca; Christ, Lisa; Scholz, Godehard; Stalder, Odile; Kollert, Florian; Reichenbach, Stephan; Villiger, Peter (2021). Vision loss in patients with giant cell arteritis treated with tocilizumab. Arthritis research & therapy, 23(1), p. 92. BioMed Central 10.1186/s13075-021-02480-4
Arthritis Research & Therapy
Objectives Giant cell arteritis (GCA) may lead to vision loss. To what extent tocilizumab (TCZ) is able to prevent vision loss is unknown. The aim was to analyze the occurrence of vision loss in a large GCA cohort treated with TCZ. Methods In this ob
Autor:
Xuan Yuan, Lidan Ma, Hailong Li, Yuwei He, Lingling Cui, Nan Liang, Aichang Ji, Hui Zhang, Xiaoyu Cheng, Ting Xu, Xiaomei Xue, Mingshu Sun, Changgui Li, Xinjiang Wu, Can Wang, Wenyan Sun, Ruixia Sun
Publikováno v:
Arthritis Research & Therapy, Vol 21, Iss 1, Pp 1-9 (2019)
Arthritis Research & Therapy
Arthritis Research & Therapy
Background Low doses of febuxostat or benzbromarone are widely used in Asian countries, but lacking studies to compare the efficacy and safety of the two urate-lowering drugs. Methods To compare the efficacy and safety of low-dose febuxostat with low
Autor:
Wen-Ching Lan, Wen-Yi Tseng, Chang-Fu Kuo, Meng-Jiun Chiou, Ting-Ting Chung, Lian-Chin Wang, Kuang-Hui Yu, Jung-Sheng Chen, Ao-Ho Hsieh, Shue-Fen Luo
Publikováno v:
Arthritis Research & Therapy, Vol 21, Iss 1, Pp 1-9 (2019)
Arthritis Research & Therapy
Arthritis Research & Therapy
Background This study investigates the association between exposure to urate-lowering drugs (ULDs) and progression and recovery from chronic kidney disease (CKD). Methods We identified 5860 incident gout patients at Chang Gung Memorial Hospital from
Autor:
Jean-Pierre Pelletier, Marc Dorais, François Abram, Johanne Martel-Pelletier, Jean-Pierre Raynauld, Philippe Delorme
Publikováno v:
Arthritis Research & Therapy, Vol 20, Iss 1, Pp 1-10 (2018)
Arthritis Research & Therapy
Arthritis Research & Therapy
Background The weight of recommendation for intra-articular therapies such as hyaluronic acid injections varies from one set of guidelines to another, and they have not yet reached unanimity with respect to the usefulness of intra-articular hyaluroni
Autor:
Dandan Wang, Huayong Zhang, Bingzhu Hua, Jun Liang, Hong Wang, Lingyun Sun, Xiaojun Tang, Fan Wang, Xuebing Feng
Publikováno v:
Arthritis Research & Therapy, Vol 19, Iss 1, Pp 1-8 (2017)
Arthritis Research & Therapy
Arthritis Research & Therapy
Background Systemic sclerosis (SSc) is an autoimmune disease involving the skin and several internal organs. Most therapies available for this disease are symptomatic. Given the difficulty in treating SSc, we conducted this study to investigate the e
Publikováno v:
Arthritis Research & Therapy, Vol 20, Iss 1, Pp 1-2 (2018)
Arthritis Research & Therapy
Arthritis Research & Therapy
Diuretics have been associated with impaired response and refractoriness in gout, but whether this effect is still present with new urate-lowering drugs (ULD) and treat-to-target strategies is unknown. The aim of the present study was to assess the i